ABA
BMY icon

American Beacon Advisors’s Bristol-Myers Squibb BMY Stock Holding History

American Beacon Advisors’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-1,967
Closed -$122K – 29
2018
Q3 		$122K Hold
1,967
– – 0.83% 52
2018
Q2 		$109K Hold
1,967
– – 1% 53
2018
Q1 		$124K Buy
+1,967
New +$127K 1.32% 32

Other funds holding BMY

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

American Beacon Advisors's BMY Position: Q4 2018 in Review

American Beacon Advisors sold out of Bristol-Myers Squibb (BMY) in Q4 2018, closing a stake of 1,967 shares — an estimated $122K sold.

American Beacon Advisors first reported a position in BMY in Q1 2018 and held it in 3 quarters. The position peaked at $124K in Q1 2018. 1,765 funds tracked by Wall St. Rank hold BMY as of Q4 2018.

  • American Beacon Advisors reported no remaining Bristol-Myers Squibb position as of Q4 2018 after selling out during the quarter.
  • American Beacon Advisors sold 1,967 Bristol-Myers Squibb shares in Q4 2018, an estimated $122K.
  • American Beacon Advisors first reported a position in Bristol-Myers Squibb in Q1 2018 and held it in 3 quarters.
  • American Beacon Advisors's Bristol-Myers Squibb position peaked at $124K in Q1 2018.
  • 1,765 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2018.

Based on American Beacon Advisors's 13F filing for Q4 2018, filed 15 Feb 2019.